Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenylephrine vs Taping for Ptosis Evaluation
NCT05890027Phase 4Completed
- Sponsor
- University of Miami
- Start
- Mar 2024
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of phenylephrine in blepharoptosis, sponsored by University of Miami. Primary endpoints: Mean Margin Reflex Distance 1, Mean Change in Margin Reflex Distance 1 and 3 more. Started Mar 2024; status: completed.
02
Drugs
phenylephrine
03
Conditions
blepharoptosis
Beyond the preview
Go deeper on NCT05890027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05890027.